Free Trial

Elevance Health (ELV) Stock Price, News & Analysis

Elevance Health logo
$378.83 -6.73 (-1.75%)
(As of 03:15 PM ET)

About Elevance Health Stock (NYSE:ELV)

Key Stats

Today's Range
$378.27
$390.27
50-Day Range
$382.14
$509.58
52-Week Range
$378.27
$567.26
Volume
998,072 shs
Average Volume
1.22 million shs
Market Capitalization
$87.86 billion
P/E Ratio
13.81
Dividend Yield
1.72%
Price Target
$539.20
Consensus Rating
Moderate Buy

Company Overview

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Elevance Health Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
99th Percentile Overall Score

ELV MarketRank™: 

Elevance Health scored higher than 99% of companies evaluated by MarketBeat, and ranked 24th out of 954 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Elevance Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.81, and is based on 12 buy ratings, 2 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Elevance Health has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Elevance Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Elevance Health are expected to grow by 7.25% in the coming year, from $32.96 to $35.35 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Elevance Health is 13.86, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 136.40.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Elevance Health is 13.86, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 134.21.

  • Price to Earnings Growth Ratio

    Elevance Health has a PEG Ratio of 1.14. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Elevance Health has a P/B Ratio of 2.25. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.22% of the float of Elevance Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Elevance Health has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Elevance Health has recently decreased by 9.90%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Elevance Health pays a meaningful dividend of 1.71%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Elevance Health has been increasing its dividend for 13 years.

  • Dividend Coverage

    The dividend payout ratio of Elevance Health is 23.77%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Elevance Health will have a dividend payout ratio of 18.44% next year. This indicates that Elevance Health will be able to sustain or increase its dividend.

  • Read more about Elevance Health's dividend.
  • Percentage of Shares Shorted

    1.22% of the float of Elevance Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Elevance Health has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Elevance Health has recently decreased by 9.90%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Elevance Health has a news sentiment score of 1.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.79 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 20 news articles for Elevance Health this week, compared to 14 articles on an average week.
  • Search Interest

    Only 25 people have searched for ELV on MarketBeat in the last 30 days. This is a decrease of -48% compared to the previous 30 days.
  • MarketBeat Follows

    Only 18 people have added Elevance Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -28% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Elevance Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,205,182.00 in company stock.

  • Percentage Held by Insiders

    Only 0.29% of the stock of Elevance Health is held by insiders.

  • Percentage Held by Institutions

    89.24% of the stock of Elevance Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Elevance Health's insider trading history.
Receive ELV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elevance Health and its competitors with MarketBeat's FREE daily newsletter.

ELV Stock News Headlines

Elevance Health: A Quality Underpriced Stock Returning To Health
Set Your Portfolio Up for Success in 2025…
Set Your Portfolio Up for Success in 2025… Charles Payne’s beginner-friendly options strategies
What the Options Market Tells Us About Elevance Health
Elevance Health (NYSE:ELV) Sets New 1-Year Low - Here's Why
See More Headlines

ELV Stock Analysis - Frequently Asked Questions

Elevance Health's stock was trading at $471.56 at the beginning of the year. Since then, ELV shares have decreased by 19.4% and is now trading at $380.10.
View the best growth stocks for 2024 here
.

Elevance Health, Inc. (NYSE:ELV) released its earnings results on Thursday, October, 17th. The company reported $8.37 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $9.66 by $1.29. The business's quarterly revenue was up 5.3% on a year-over-year basis.

The following companies are subsidiaries of Elevance Health: Beacon Health Options, Aspire Healthcare Corp, America’s 1st Choice, HealthSun Health Plans, Simply Healthcare Holdings, Amerigroup, 1-800 Contacts, and others.

Elevance Health's top institutional shareholders include State Street Corp (4.61%), Geode Capital Management LLC (2.09%), FMR LLC (1.99%) and Sanders Capital LLC (1.99%). Insiders that own company stock include Gail Boudreaux, Gloria M Mccarthy, Felicia F Norwood, Robert L Dixon Jr, Ramiro G Peru, Charles Morgan Kendrick Jr, Ronald W Penczek and Peter D Haytaian.
View institutional ownership trends
.

Shares of ELV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Elevance Health investors own include NVIDIA (NVDA), Chevron (CVX), Meta Platforms (META), Advanced Micro Devices (AMD), Bristol-Myers Squibb (BMY), Netflix (NFLX) and JPMorgan Chase & Co. (JPM).

Company Calendar

Ex-Dividend for 9/25 Dividend
9/10/2024
Dividend Payable
9/25/2024
Last Earnings
10/17/2024
Ex-Dividend for 12/20 Dividend
12/05/2024
Today
12/12/2024
Dividend Payable
12/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Hospital & medical service plans
Sub-Industry
Managed Health Care
CUSIP
94973V10
Employees
104,900
Year Founded
2004

Price Target and Rating

Average Stock Price Target
$539.20
High Stock Price Target
$649.00
Low Stock Price Target
$478.00
Potential Upside/Downside
+39.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.81
Research Coverage
16 Analysts

Profitability

Net Income
$5.99 billion
Pretax Margin
4.76%

Debt

Sales & Book Value

Annual Sales
$171.34 billion
Cash Flow
$41.60 per share
Book Value
$169.07 per share

Miscellaneous

Free Float
231,250,000
Market Cap
$89.43 billion
Optionable
Optionable
Beta
0.83

Social Links

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NYSE:ELV) was last updated on 12/12/2024 by MarketBeat.com Staff
From Our Partners